AbbVie (NY:ABBV)

265.76 +2.94 (+1.12%)

Official Closing Price Updated: 4:10 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock ↗

October 23, 2025

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock

Via The Motley Fool

Topics Economy Regulatory Compliance

Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing ↗

October 23, 2025

Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing

Via The Motley Fool

Topics Regulatory Compliance

Investment Manager Doubles Down on Regional Bank Stock, According to Recent Filing ↗

October 23, 2025

Investment Manager Doubles Down on Regional Bank Stock, According to Recent Filing

Via The Motley Fool

Topics Credit Cards Regulatory Compliance

Motley Fool Co-Founder Tom Gardner: The Quarterly Call ↗

October 22, 2025

In our second Quarterly Call, Motley Fool CEO and co-founder Tom Gardner talked about the current market and what to do about it. Tom also shared five investment ideas.

Via The Motley Fool

Topics Artificial Intelligence

AbbVie: Navigating Challenges and Seizing Opportunities in the Pharma Sector ↗

October 22, 2025

Could AbbVie be the next big opportunity for investors? Tune in as our experts dissect the company's performance and future potential.

Via The Motley Fool

Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence

October 22, 2025

San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the...

Via MarketMinute

Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades' ↗

October 22, 2025

Jason Snipe stays long on AbbVie (ABBV). Guggenheim analyst raises price target. QUALCOMM (QCOM) picked by Jim Lebenthal. Stephanie Link picks Aptiv (APTV). Joe Terranova chooses Palo Alto Networks...

Via Benzinga

This Florida Fund Is Betting $21 Million on Vertiv as AI Data Center Growth Accelerates ↗

October 21, 2025

This Florida Fund Is Betting $21 Million on Vertiv as AI Data Center Growth Accelerates

Via The Motley Fool

Topics Artificial Intelligence Supply Chain

Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market ↗

October 21, 2025

Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market

Via The Motley Fool

Topics Regulatory Compliance

Why This Florida Fund Locked In DoorDash Gains After a 70% Stock Surge ↗

October 21, 2025

Via The Motley Fool

Topics Regulatory Compliance

Florida Fund Takes $17 Million Stake in Tapestry Amid Luxury Retail Stock's Big Rally ↗

October 21, 2025

Via The Motley Fool

Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic ↗

October 17, 2025

Greg Miley stated that he will join Novo Nordisk next month as the company’s senior vice president of corporate affairs.

Via Stocktwits

Topics Government

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

October 16, 2025

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

Via The Motley Fool

3 Top Dividend Growth Stocks to Buy Right Now ↗

October 15, 2025

These dividend growth stocks merit serious consideration.

Via The Motley Fool

Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades' ↗

October 14, 2025

Analysts discuss stock performance and potential of AbbVie Inc, Amazon, Sixth Street Specialty Lending, and Datadog. Check out premarket coverage.

Via Benzinga

2 Profitable Stocks to Research Further and 1 We Avoid

October 14, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today ↗

October 13, 2025

Via Benzinga

VIX Roars Back: Trade Tensions Ignite "Fear Gauge," Signaling Potential Market Shift

October 13, 2025

The financial markets were gripped by a sudden wave of apprehension this past week as the Cboe Volatility Index (VIX), often dubbed the "fear gauge," experienced its most significant single-day surge...

Via MarketMinute

Topics Artificial Intelligence Bonds ETFs

AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug ↗

October 13, 2025

In the second quarter, Rinvoq was the second most revenue-generating drug from AbbVie’s portfolio after Skyrizi.

Via Stocktwits

2 Dividend Stocks to Double Up on Right Now ↗

October 13, 2025

These two companies can help you sleep easy at night.

Via The Motley Fool

Topics Economy Intellectual Property World Trade

iShares CUD: Navigating the Nuances of Dividend Growth in a Dynamic Market

October 10, 2025

As the closing bell rings on October 10, 2025, the iShares US Dividend Growers Index ETF (CAD-Hedged) (TSX: CUD) stands as a crucial barometer for Canadian income investors seeking exposure to...

Via MarketMinute

Topics Bonds ETFs Economy

JPMorgan Elevates Incyte Price Target Amidst Robust Pipeline and Commercial Success, Yet Maintains Cautious "Neutral" Stance

October 10, 2025

JPMorgan Chase & Co. (NYSE: JPM) has recently recalibrated its outlook on the biopharmaceutical giant Incyte Corporation (NASDAQ: INCY), with a notable upward revision of its price target for the...

Via MarketMinute

Topics Economy Intellectual Property

Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Economy Intellectual Property Retirement

Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing ↗

October 09, 2025

Via The Motley Fool

Topics Government World Trade

A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know ↗

October 08, 2025

Via Benzinga

Why AbbVie and Johnson & Johnson Could Outperform Pfizer ↗

October 08, 2025

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

Via MarketBeat

Why AbbVie Stock Soared in September ↗

October 08, 2025

It was a month stuffed with several different kinds of wins for the pharmaceutical company.

Via The Motley Fool

Topics Regulatory Compliance

Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025

October 07, 2025

On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership...

Via MarketMinute

Topics Artificial Intelligence ETFs Intellectual Property

Red Spruce Capital Dumps 35K SouthState Bank (SSB) Shares Worth $3.2 Million ↗

October 07, 2025

Via The Motley Fool

Topics Credit Cards Regulatory Compliance

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.